Food News and Research

RSS

Pten gene can also fight against obesity, ageing process

This result, obtained after five years' research, is published in leading journal Cell Metabolism. The authors, led by Manuel Serrano (CNIO), believe it will open the door to new therapeutic options not only against cancer, but against obesity and even the ageing process.

7 Mar 2012

Researchers reveal how melanoma develops resistance to Zelboraf

Cancer is tough to kill and has many ways of evading the drugs used by oncologists to try and eliminate it. Now, researchers at UCLA's Jonsson Comprehensive Cancer Center have uncovered how an advanced form of melanoma gets around an inhibitor, Zelboraf, which targets the mutated BRAF gene.

7 Mar 2012

Tree nut consumption may reduce weight and health risks

March is National Nutrition Month and as the spotlight shines on all things healthy, celebrate with a mindful snack that loves you back-California pistachios.

7 Mar 2012

Viewpoints: Contraception politics; Better food labels; Opposing stands on ultrasounds and abortion

Between the flap at the Susan G. Komen for the Cure and the squall about the Obama administration's directive that health insurance plans cover the cost of birth control, contraception is shaping up as one of the year's biggest political land mines.

7 Mar 2012

FDA issues Complete Response Letter to Eisai for Dacogen sNDA

Astex Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter to partner Eisai for their supplemental New Drug Application (sNDA) for Dacogen (decitabine) for Injection for patients with acute myeloid leukemia (AML) in adults 65 years of age or older who are not considered candidates for induction therapy.

7 Mar 2012

FDA approves Discovery Labs' SURFAXIN to prevent Respiratory Distress Syndrome

Discovery Laboratories, Inc., a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced that the United States Food and Drug Administration (FDA) has approved SURFAXIN (lucinactant) for the prevention of Respiratory Distress Syndrome (RDS) in premature infants at high risk for RDS.

6 Mar 2012

Viewpoints: Statins and diabetes; Frightening tobacco warnings; The U.S. dental crisis

We're overdosing on cholesterol-lowering statins, and the consequence could be a sharp increase in the incidence of Type 2 diabetes. This past week, the Food and Drug Administration raised questions about the side effects of these drugs and developed new labels for these medications that will now warn of the risk of diabetes and memory loss.

6 Mar 2012

Sleep specialists offer advice on why Daylight Saving Time can be hazardous to health

It's National Sleep Awareness Week, and Loyola University Health System sleep specialists are offering advice on -- Why Daylight Saving Time, which begins Sunday, March 11, can be hazardous to your health.

6 Mar 2012

Merck announces results from AIT Phase III clinical study for ragweed allergy

Merck, known as MSD outside the United States and Canada, today announced the results from a Phase III clinical study of its investigational allergy immunotherapy tablet (AIT) for ragweed pollen.

6 Mar 2012

Sodexo obtains ISO 22000:2005 Food Safety Management System certification

Reinforcing its commitment to the 10 million customers it serves daily, Sodexo, Inc., leading provider of Quality of Daily Life Solutions, recently obtained ISO (International Organization of Standardization) 22000:2005 certification for its food management systems in the U.S. and Canada, which focuses on ensuring food safety and quality from farm to fork.

6 Mar 2012

Santarus fourth quarter total revenues increase 65% to $42.6M

Santarus, Inc. (NASDAQ: SNTS) today reported financial and operating results for the three and 12 month periods ended December 31, 2011.

5 Mar 2012

Astex fourth quarter total revenues increase to $21.2 million

Astex Pharmaceuticals, Inc., today reported financial results for the fourth quarter and year ended December 31, 2011.

5 Mar 2012

FDA accepts Eisai's resubmission of perampanel NDA for review

Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's resubmission of the New Drug Application (NDA) for perampanel (E2007), an investigational drug, for the treatment of partial-onset seizures associated with epilepsy.

5 Mar 2012

Sun-dried tomatoes may be contaminated with hepatitis A virus: Officials warn

The Health Protection Agency (HPA) said two confirmed cases of the infection had been found to have an identical strain to three cases reported in England and confirmed at HPA Colindale in 2010. Both people had recently eaten sun-dried tomatoes.

5 Mar 2012

Merck fails to get FDA nod for new cholesterol lowering combo pill

The length of delay in approval is not clear yet as the FDA has called for additional study data on the compound. It combines generic Lipitor (Atorvastatin), the top-selling drug of all time, with Merck's cholesterol medicine Zetia (Ezetimibe).

5 Mar 2012

Merck announces success of pill against ragweed allergy

Merck & Co. announced Monday that their experimental allergy tablet reduced allergic reactions to ragweed and helped patients use less medication to treat their symptoms.

5 Mar 2012

$Vitamin D in pre-teen girls protects from stress fractures and bone injuries: Study$

Vitamin D in pre-teen girls protects from stress fractures and bone injuries: Study

A new study shows that girls and young women who got lots of vitamin D through their diet and supplements were half as likely to suffer a stress fracture as those who didn't.

5 Mar 2012

USAID committed to early action on Sahel drought, drawing from lessons from Horn response

"A year after the worst drought in 60 years sent 13.3 million people in the Horn of Africa into crisis, we are now facing a rising threat of crisis in the Sahel -- an arid belt that stretches from Senegal through Niger and Burkina Faso to Chad," Nancy Lindborg, head of democracy, conflict, and humanitarian assistance at USAID, writes in this post in Huffington Post's "The Blog."

5 Mar 2012

Thrombotech receives FDA IND approval for THR-18 Phase IIa clinical trial in stroke victims

Hadasit Bio-Holdings a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced Thrombotech Ltd., a portfolio company which Hadasit holds a 24% stake in, received an IND approval from the Food and Drug Administration enabling the initiation of a Phase IIa clinical trial in the U.S.

5 Mar 2012

FDA clears UELS contactless breast cancer imaging tool

UE LifeSciences Inc. (UELS), a medical device manufacturer focused on providing novel breast cancer screening solutions, announced today that it has received market clearance from the U.S. Food and Drug Administration (FDA) for its NoTouch BreastScan™ device. NoTouch BreastScan™ is a contactless breast-imaging tool cleared by the FDA specifically for adjunctive diagnostic screening for the detection of breast cancer.

5 Mar 2012